Dr. Andrew E. Sloan Has Been Recognized Among the Top in His Industry by the Expert Network©
The Expert Network celebrates its newest member, Dr. Andrew E. Sloan
Cleveland, OH, May 23, 2016 (Newswire.com) - Dr. Andrew E. Sloan, Director, Brain Tumor and Neuro-Oncology Center, UH Case Medical Center, has joined The Expert Network, an invitation only service for distinguished professionals. Dr. Sloan has been chosen as a Distinguished Doctor™ based on peer reviews and ratings, numerous recognitions, and accomplishments achieved throughout his career.
Dr. Sloan outshines others in his field due to his extensive educational background, numerous awards and recognitions, and career longevity. After earning his Bachelor of Science from Yale University magna cum laude in 1985, he went on to receive his medical degree from Harvard Medical School in 1990. He then completed an internship in general surgery and a residency in neurological surgery at UCLA's David Geffen School of Medicine, followed by a fellowship at University of Texas MD Anderson Cancer Center. Dr. Sloan is Board Certified by the American Board of Neurological Surgery.
"We're doing things in an increasingly minimally invasive fashion, and we are starting to implement innovative approaches. Today, we are doing gene therapy, stem cell therapy, and immunotherapy. Those are things I'm very interested in."
Andrew E. Sloan, M.D., FACS, Director, Brain Tumor and Neuro-Oncology Center, UH Case Medical Center
With 20 years dedicated to medicine, Dr. Sloan brings a wealth of knowledge to his industry, and in particular, to his area of expertise, neurosurgical oncology. When asked why he decided to pursue a career in medicine, Dr. Sloan said:
"I had two family members die of cancer when I was in my early teens. They were both young and seemed to me to be otherwise pretty healthy, so it was very shocking to me that something like that could happen. I was a scientifically oriented kid, so I said to myself ‘maybe I can help, prevent this from happening to someone else.’"
In 2007, Dr. Sloan joined UH Case Western Reserve, and the Case Comprehensive Cancer Center. Prior to coming to Cleveland, he was on faculty at the University of South Florida H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, as well as Wayne State University and the Karmanos Cancer Institute in Detroit, Michigan. Throughout his industrious career, he has held the role of visiting professor for countless residency students.
As a leader in his industry, Dr. Sloan is highly lauded for his research and contributions to neurosurgery. He has been recognized by his peers as one of the “Best Doctors in America” since 2003, and as one of the “Top Surgeons in America” since 2007. He has also received numerous other awards and recognitions over the course of his career, including the Clinical Research Career Development Award from the American Society of Clinical Oncology (ASCO) in 2000, and the National Brain Tumor Foundation Mahaley Award for Clinical Research in Neuro-Oncology, conferred at the 81st Annual AANS meeting on April 2013, among many others. In 2014, he was elected President of the Ohio State Neurosurgical Society (OSNS).
Dr. Sloan is perhaps best known for his innovative research on glioma vaccines and glioma stem cells, which has been funded by many prominent national organizations, including the National Institute of Health (NIH), National Cancer Institute (NCI), Ohio Third Frontier organization, American Society of Clinical Oncology (ASCO), and the American Brain Tumor Association (ABTA). Working at the cutting-edge of the field, he is currently helping to develop a new generation of neurosurgical simulators.
This prominence in the field gives Dr. Sloan a unique vantage point from which to follow prevailing trends in neurosurgery. Over the course of nearly twenty years practicing as a neurosurgeon, Dr. Sloan has been witness to some industry-wide shifts:
"We're doing things in an increasingly minimally invasive fashion, and we are starting to implement innovative approaches. Today, we are doing gene therapy, stem cell therapy, and immunotherapy. Those are things I'm very interested in."
Dr. Sloan is the Director of the Brain Tumor and Neuro-Oncology Center at UH Seidman Cancer Center and the Neurological Institute, and serves as Professor and Vice-Chair of Neurosurgery at Case Western Reserve University School of Medicine, with joint appointments in Pathology and the Center for Translational Neuroscience. He also holds the Peter D. Cristal Endowed Chair in Neurosurgery at University Hospitals. He is a member of the American Association of Neurological Surgery (AANS) and the American College of Surgeons, Oncology Group (ACOSOG).
For more information, visit Dr. Sloan's profile on the Expert Network here: http://expertnetwork.co/members/andrew-e-sloan,-md,-facs/06a071a816397d72
###
The Expert Network has written this news release with approval and/or contributions from Dr. Andrew E. Sloan. The Expert Network is an invitation-only reputation management service that is dedicated to helping professionals stand out, network, and gain a competitive edge. The Expert Network selects a limited number of professionals based on their individual recognitions and history of personal excellence.
Source: The Expert Network